NGS is changing GxP compliance. Will you adapt?
Bio Pharma Dive
MARCH 17, 2025
Discover NGS for GxP compliance with full audit trails, operational control and robust data security.
Mon.Mar 17, 2025
246 
Advanced Biomed IPO Raises $6.56M Towards Liquid Biopsy Testing
XTalks
MARCH 17, 2025
On March 7, 2025, Advanced Biomed Inc. raised $6.56 million in its IPO and began trading on Nasdaq under the ticker ADVB. The biotech firm, which develops semiconductor-based microfluidic technology for early cancer detection, issued 1.64 million shares at $4 each, with an option to purchase an additional 246,000 shares within 45 days. Current Share Price: Established in 2014, Advanced Biomed has developed a proprietary microfluidic platform that functions as a compact laboratory on a chip.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
How biotech and pharma teams are reaching LPI ahead of schedule
Bio Pharma Dive
MARCH 17, 2025
With the right strategy, reaching LPI ahead of schedule isn’t a myth. Learn how some biotech and pharma teams are achieving the impossible.
Taiho outlays $1.14bn to acquire ADC specialist Araris
Pharmaceutical Technology
MARCH 17, 2025
Taiho is turning its long-time ADC partner into a wholly owned subsidiary with the acquisition.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Latigo raises $150M to get non-opioid pain drugs through key tests
Bio Pharma Dive
MARCH 17, 2025
The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for its lead candidate.
Azurity acquires Covis Pharma from existing investors
Pharmaceutical Technology
MARCH 17, 2025
Azurity Pharmaceuticals has acquired Covis Group from existing investors, making the latter a wholly owned subsidiary.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Investigating key strategies for optimising clinical trial supply chains in 2025
Pharmaceutical Technology
MARCH 17, 2025
Experts at the 2025 Clinical Trial Supply New England conference will discuss strategies for optimising clinical supply chains.
AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal
Bio Pharma Dive
MARCH 17, 2025
The British drugmaker is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer as well as autoimmune conditions.
Incyte stock hit 11% despite paediatric dermatology trials hitting target
Pharmaceutical Technology
MARCH 17, 2025
The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.
Taiho buys Swiss biotech and its ADC tech for $400M
Bio Pharma Dive
MARCH 17, 2025
The pharma will acquire Araris Biotech to gain access to a trio of preclinical ADCs and a linking technology Araris claims is superior to conventional platforms.
Latigo secures $150m for non-opioid pain treatment development
Pharmaceutical Technology
MARCH 17, 2025
Latigo has secured $150m in a Series funding round, which will be used to further the development of its Nav1.8 inhibitors.
Budgeting and Contracting Best Practices for Research Sites
ACRP blog
MARCH 17, 2025
This is a sponsored message. To grow your business, negotiate and collect fair payment for your work by understanding its true costs before budget discussions. This includes all direct and indirect costs, and typically covers: Personnel costs: salaries, overtime, training, and additional staffing if needed. Facility costs: not only facility space, maintenance, utilities, and equipment, but also any additional space or modifications needed for the study.
EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy
Pharmaceutical Technology
MARCH 17, 2025
The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).
Roche Invests $5.3B in Zealand’s Petrelintide, an Obesity Drug Candidate
XTalks
MARCH 17, 2025
Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity. Under the deal, Zealand Pharma will receive an upfront cash payment of $1.65 billion $1.4 billion at closing and an additional $250 million over the first two anniversaries.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers
Pharmaceutical Technology
MARCH 17, 2025
While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring data integrity requires expertise and in-country support services.
Anocca announces authorisation pancreatic cancer trial
Pharma Times
MARCH 17, 2025
VIDAR-1 trial marks company's clinical-stage debut
Marketing Strategies for Pharma Brands: Driving HCP Engagement
Pharma Marketing Network
MARCH 17, 2025
Table of Contents Understanding the Importance of HCP Engagement in Pharma Marketing Key Marketing Strategies for Pharma Brands to Reach HCPs Optimizing Digital and Paid Media Strategies for Pharma Marketing Measuring Success: Tracking HCP Engagement and ROI Understanding the Importance of HCP Engagement in Pharma Marketing Engaging healthcare professionals (HCPs) effectively is a top priority for pharmaceutical brands.
Careology and Entia join forces to transform cancer care
Pharma Times
MARCH 17, 2025
Collaboration brings remote care to cancer patients
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
How to Implement a Successful Generic Drug Launch Strategy
Drug Patent Watch
MARCH 17, 2025
Unlock the Secrets to a Successful Generic Drug Launch Are you a pharmaceutical executive looking to bring a generic version of a popular medication to market? Or perhaps you're a healthcare professional interested in understanding the intricacies of generic drug launches? Whatever your role, a successful generic drug launch requires careful planning, strategic execution, and a deep understanding of the regulatory landscape.
DDW Highlights: 17 March 2025
Drug Discovery World podcast
MARCH 17, 2025
The latest episode of the DDW Highlightspodcast is now available to listen to below. DDWs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Clinical trials of all stages have dominated the DDW news section this week. All the stories represent a significant step forward for drug discovery, either due to the innovative nature of the therapies being studied, or the unique methods employed in the trial.
Managing Drug Patent Litigation Costs
Drug Patent Watch
MARCH 17, 2025
The Hidden Costs of Drug Patent Litigation: How to Stay Ahead of the Game As a pharmaceutical professional, you're no stranger to the complexities of drug patent litigation. The stakes are high, and the costs can be astronomical. But what if I told you that there's a way to manage these costs and stay ahead of the game? In today's fast-paced pharmaceutical landscape, patent litigation is an inevitable reality.
Latigo raises $150m for non-opioid painkiller push
pharmaphorum
MARCH 17, 2025
Latigo has tapped into investor interest in pain relief medicines with new, non-opioid mechanisms of action, raising $150 million in a Series B
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Future of Wearable Technology in Clinical Trials
Crucial Data Soutions
MARCH 17, 2025
What Are Wearables and How Are They Used in Clinical Trials? Wearable technology is transforming clinical trials by making it. The post The Future of Wearable Technology in Clinical Trials appeared first on Crucial Data Solutions.
Taiho snaps up ADC partner Araris for up to $1.14bn
pharmaphorum
MARCH 17, 2025
Taiho has reached a deal to buy Swiss biotech Araris, around 18 months after they started collaborating on antibody-drug conjugates for cancer
The Impact of Automation on Costs and Variability
Pharmaceutical Commerce
MARCH 17, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, comments on how he envisions automation in the CAR-T manufacturing space playing a role in improving efficiency, reducing costs, and ultimately, expanding patient access.
PM Society Awards 2025: For every patient, every person
pharmaphorum
MARCH 17, 2025
The PM Society Awards 2025, hosted by Sue Perkins and Alan Dedicoat, celebrate excellence in healthcare marketing. Join us as we honour innovations that put every patient and person at the forefront.
Protecting Your Data: Our Updated Privacy Policy
Antidote
MARCH 17, 2025
Select your language: At Antidote, we take the protection of your personal information seriously. We understand that your privacy is important, and we are committed to keeping your data safe, private, and secure. We constantly monitor and remain compliant with the latest regulations, ensuring that your information is handled responsibly.
3rd Gene Therapy Potency Assay Summit 2025
pharmaphorum
MARCH 17, 2025
3rd Gene Therapy Potency Assay Summit 2025 Sara.
Pharma Pulse 3/17/25: Dual Trial Strategies, Executive Order Advances Price Transparency Efforts & more
Pharmaceutical Commerce
MARCH 17, 2025
The latest news for pharma industry insiders.
Inaugural Dark Genome Target Discovery & Development Summit
pharmaphorum
MARCH 17, 2025
Inaugural Dark Genome Target Discovery & Development Summit Sara.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content